Geneos Wealth Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7
Closed -$564 2497
2025
Q4
$564 Hold
7
﹤0.01% 2453
2025
Q3
$574 Sell
7
-625
-99% -$54.2K ﹤0.01% 2456
2025
Q2
$57.6K Sell
632
-68
-10% -$6.08K ﹤0.01% 1492
2025
Q1
$64.1K Buy
700
+477
+214% +$41.6K ﹤0.01% 1352
2024
Q4
$19K Sell
223
-155
-41% -$13.6K ﹤0.01% 1751
2024
Q3
$33.1K Buy
378
+298
+373% +$25.1K ﹤0.01% 1352
2024
Q2
$6.32K Sell
80
-4
-5% -$329 ﹤0.01% 1666
2024
Q1
$7.6K Hold
84
﹤0.01% 1609
2023
Q4
$7.39K Buy
84
+7
+9% +$583 ﹤0.01% 1627
2023
Q3
$6.51K Buy
+77
New +$6.96K ﹤0.01% 1669
2022
Q4
Sell
-55
Closed -$4K 2036
2022
Q3
$4K Hold
55
﹤0.01% 1728
2022
Q2
$4K Sell
55
-13
-19% -$1.07K ﹤0.01% 2248
2022
Q1
$5K Buy
68
+13
+24% +$1.02K ﹤0.01% 2323
2021
Q4
$4K Hold
55
﹤0.01% 2450
2021
Q3
$4K Hold
55
﹤0.01% 2498
2021
Q2
$4K Sell
55
-8
-13% -$618 ﹤0.01% 2501
2021
Q1
$4K Buy
+63
New +$4.76K ﹤0.01% 2709
2019
Q4
Sell
-45
Closed -$2K 2548
2019
Q3
$2K Buy
+45
New +$2.89K ﹤0.01% 2293
2019
Q1
Sell
-43
Closed -$2K 2419
2018
Q4
$2K Buy
+43
New +$2.69K ﹤0.01% 2187

Other funds holding DOX

Geneos Wealth Management's DOX Position: Q1 2026 in Review

Geneos Wealth Management sold out of Amdocs (DOX) in Q1 2026, closing a stake of 7 shares — an estimated $564 sold.

Geneos Wealth Management first reported a position in DOX in Q4 2018 and held it in 19 quarters. The position peaked at $64.1K in Q1 2025. 475 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Geneos Wealth Management reported no remaining Amdocs position as of Q1 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 7 Amdocs shares in Q1 2026, an estimated $564.
  • Geneos Wealth Management first reported a position in Amdocs in Q4 2018 and held it in 19 quarters.
  • Geneos Wealth Management's Amdocs position peaked at $64.1K in Q1 2025.
  • 475 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.